Skip to main content
Department of Health Department of Health An Roinn Sláinte Männystrie O Pouste

Main navigation

  • Home
  • Topics
  • Publications
  • Consultations
  • Contact

Translation help

Translate this page

Select a language

  • Arabic — عربي
  • Chinese (Simplified) — 中文简体
  • Chinese (Traditional) — 中文繁體
  • Dutch — Nederlands
  • Filipino — Filipino
  • French — Français
  • German — Deutsch
  • Hungarian — Magyar
  • Irish — Gaeilge
  • Italian — Italiano
  • Latvian — Latviešu
  • Lithuanian — Lietuvių kalba
  • Polish — Polski
  • Portuguese — Português
  • Romanian — Română
  • Russian — Русский
  • Slovak — Slovenčina
  • Spanish — Español
  • Ukrainian — Українська
  • Drug Alerts - 2026

    Date published: 27 January 2026

    Last updated: 17 February 2026

    Drug alerts issued by DoH during 2026

    Documents

    • PHC-01-2026 - Class 2 Medicines Recall Paliperidone Mercury Pharma 50 mg and 75mg prolonged-release suspension for injection in pre-filled syringe EL(26)A/01Adobe PDF (121.79 KB)
    • PHC-02-2026 - Class 3 Medicines Recall - Fingolimod Glenmark 0.5 mg Hard Capsules EL(26)A/02Adobe PDF (99.23 KB)
    • PHC-03-2026 - Class 4 medicines defect information, EL(26)A/03 - Ocumont Eye Ointment 1% ww batch B0866Adobe PDF (107.13 KB)
    • PHC-04-2026 - Class 4 medicines defect information, EL(26)A/04 Arixtra 1.5 mg/0.3 ml solution for injection, pre-filled syringeAdobe PDF (192.26 KB)
    • PHC-05-2026 - Class 1 Medicines Recall - Eaststone Limited, Quetiapine oral suspension, all strengths, (unlicensed medicine), NatPSA/2026/002/MHRAAdobe PDF (181.61 KB)
    • PHC-06-2026 - Class 2 Medicines Recall - Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent ) EL(26)A/05Adobe PDF (106.58 KB)
    • PHC-07-2026 - Class 2 Medicines Recall of two batches of Baclofen 10mg/5ml Oral Solution Adobe PDF (114.49 KB)
    • PHC-08-2026 - Class 3 Recall of four batches Ibuprofen Ibucalm 200mg tablets DMRC Ref-38319360 Adobe PDF (108.17 KB)
    • PHC-09-2026 - CLASS 3 MEDICINES RECALL, EL(26)A/08 – NORGINE MOVICOL Ease Citrus Powder for oral solution 13.7gAdobe PDF (105.2 KB)
    • PHC-10-2026 - Class 2 Medicines Recall KidNaps (Melatonin) 1mg in 1ml Oral Solution EL(26)A/09Adobe PDF (110.4 KB)
    • PHC-11-2026 - Class 4 Medicines Defect Information EL(26)A/10 Dropodex 0.1% w/v Eye Drops, solutionAdobe PDF (162.09 KB)
    • PHC-12-2026 - CLASS 2 MEDICINES RECALL, CRESCENT PHARMA LIMITED, RAMIPRIL 5 MG CAPSULES, EL(26)A/11 Ramipril 5 mg CapsulesAdobe PDF (248.52 KB)
    • PHC-14-2026 - Class 2 Medicines recall Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml) EL(26)A/13Adobe PDF (106.37 KB)
    • PHC-16-2026 - URGENT Class 2 Recall Notification HIBIWASH 500ml DMRC Ref-38814497 EL(26)A/15 (Please note the PHC number is allocated based on the number of Alerts issued to date and therefore does not necessarily match MHRA’s EL number)Adobe PDF (151.74 KB)
    • PHC-17-2026 - Class 4 Medicines Defect Vesomni 6 mg/0.4 mg modified release tablets EL(26)A/16.Adobe PDF (114.31 KB)
    • PHC-18-2026 - Class 4 Medicines Defect _Apixaban 2.5mg and 5mg tablets_DMRC-38614094 EL(26)A/17Adobe PDF (165.19 KB)
    • PHC-19-2026 - Class 2 Medicines Recall - EL(26)A/18 - Rabies, Human normal Immunoglobulin 500IU solution for InjectionAdobe PDF (111.73 KB)
    • PHC-20-2026 - Class 2 Medicines Recall - Ramipril 10mg Capsules EL(26)A/19. NOTE: The Department’s allocated PHC number will not always match MHRA’s EL number as one of their previous alerts was a class 1 (NatPSA) and did not have an EL number assigned Adobe PDF (361.04 KB)
    • PHC-21-2026 - Class 4 Medicines Defect Notification - Hiprex 1g tablets (Braille Labelling Error), DMRC_PROC-39194203 EL(26)A/20.Adobe PDF (126.58 KB)
    • PHC-22-2026 - Class 3 Medicines Recall - Napralief 250mg Gastro-Resistant Tablets EL(26)A/21Adobe PDF (133.43 KB)
    • PHC-23-2026 - Class 2 Medicines Recall - Sertraline 100 mg film-coated tablets EL(26)A/22Adobe PDF (215.43 KB)
    • PHC-24-2026 - Class 4 Medicines Defect - Loperamide hydrochloride 2 mg Orodispersible Tablets EL(26)A/23Adobe PDF (145.45 KB)
    • PHC-25-2026 - Class 4 Medicines Defect Notification - balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis - EL(26)A/24Adobe PDF (300.18 KB)

    Help viewing documents

    Share this page Share on Facebook (external link opens in a new window / tab) Share on X (external link opens in a new window / tab) Share by email (external link opens in a new window / tab)

    Department footer links

    • Crown copyright
    • Terms and Conditions
    • Privacy
    • Cookies
    • Accessibility
    • The Northern Ireland Executive
    • The Executive Office
    • Department of Agriculture, Environment and Rural Affairs
    • Department for Communities
    • Department for Education
    • Department for the Economy
    • Department of Finance
    • Department for Infrastructure
    • Department for Health
    • Department of Justice
    • nidirect.gov.uk — the official government website for Northern Ireland citizens